# Council Regulation (EU) 2016/369 of 15 March 2016 on the provision of emergency support within the Union, Annex: Eligible actions

Extent: E+W+S+N.I.

The following actions may be financed in case of pandemics with large‐scale effect:
(a) temporary reinforcement of the medical workforce, exchange of medical professionals, hosting foreign patients or other type of mutual support;
(b) deployment of temporary healthcare facilities and temporary extension of existing healthcare facilities to relieve pressure on existing structures and increase overall healthcare capacity;
(c) activities to support the administration of large‐scale application of medical tests and prepare the necessary scientific testing strategies and protocols;
(d) setting up temporary quarantine facilities and other appropriate measures at the Union borders;
(e) development, production or purchase and distribution of medical products;
(f) increases and conversions of production capacities for medical products as referred to in point (e) to address supply shortages;
(g) maintenance of the stock of medical products as referred to in point (e) and their disposal;
(h) actions to support the necessary steps to obtain approval for the use of the medical products as referred to in point (e) if required;
(i) actions to develop appropriate methods to track the development of the pandemic and the results of measures implemented to address it;
(j) organisation of ad‐hoc clinical trials of potential therapies or diagnostics according to trial standards agreed at Union level;
(k) scientific validation of medical products, including potential new testing methods.
The above list is not exhaustive.

---
Source: https://www.legislation.gov.uk/eur/2016/369/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2016-369/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.